Profil
Phillip Zamore is the founder of Alnylam Pharmaceuticals, Inc., founded in 2002.
Dr. Zamore is the founder of Voyager Therapeutics, Inc., founded in 2013.
Dr. Zamore currently holds the position of Chairman at RNA Therapeutics Institute.
Dr. Zamore currently holds the position of Professor at UMass Chan Medical School.
Dr. Zamore completed undergraduate and doctorate degrees at Harvard University.
Aktive Positionen von Phillip Zamore
| Unternehmen | Position | Beginn |
|---|---|---|
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
RNA Therapeutics Institute | Vorsitzender | - |
Ehemalige bekannte Positionen von Phillip Zamore
| Unternehmen | Position | Ende |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Gründer | - |
| VOYAGER THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Phillip Zamore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
RNA Therapeutics Institute |
















